Format

Send to

Choose Destination
Am J Psychiatry. 1987 Aug;144(8):1071-3.

An open trial of L-tyrosine in the treatment of attention deficit disorder, residual type.

Abstract

To elucidate the role of catecholamines in attention deficit disorder, the authors conducted an open 8-week trial of L-tyrosine in 12 adults with attention deficit disorder, residual type. Eight showed marked to moderate clinical response in 2 weeks; at 6 weeks these eight developed tolerance, suggesting that L-tyrosine is not useful in attention deficit disorder, residual type.

PMID:
3300376
DOI:
10.1176/ajp.144.8.1071
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center